跳至主要内容
临床试验/KCT0004825
KCT0004825招募中未知

Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid Leukemia

Chonnam National University Hospital Hwasun Hospital0 个研究点目标入组 620 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
620

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients with newly diagnosed with acute myeloid leukemia by 4th edition of WHO criteria
  • 19 years of age or greater
  • Patients will receive intensive induction therapy
  • Female patients of childbearing potential must have negative pregnancy test results at entry.
  • Ability to understand the study objectives and willingness to sign written consent

排除标准

  • Have other active malignancy
  • Pregnant of lactating women
  • Patients who have no desire to participate in the study
  • Isolated extramedullary myeloid sarcoma
  • Diagnosed with acute promyelocytic leukemia (APL) (FAB classification: M3).

研究者

发起方
Chonnam National University Hospital Hwasun Hospital

相似试验